Clinical Trials · NCT03555578
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 1,905
- Start date
- Nov 2017
- Locations
- 1 site, Japan
- Primary endpoint
- Percentage of Participants who had One or More Adverse Drug Reactions